The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma

DOI: 10.4046/trd.2018.0019

Keywords: Carcinoma, Non-Small-Cell Lung, Chemotherapy, Docetaxel, Treatment Outcome, Safety, Therapeutics, Aged, Lung Neoplasms, Carcinoma, Squamous Cell

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text